Document Detail


Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
MedLine Citation:
PMID:  20656215     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The lecithin:cholesterol acyltransferase (LCAT) enzyme is responsible for the synthesis of cholesteryl esters in human plasma. Lecithin:cholesterol acyltransferase is a critical enzyme in high-density lipoprotein (HDL) metabolism, and deficiency of LCAT-mediated cholesterol esterification leads to defective HDL maturation with accumulation of nascent pre-beta HDL. In addition to its function in HDL metabolism, LCAT has also long been believed to play a critical role in macrophage reverse cholesterol transport (RCT). However, recent findings have shown that human LCAT overexpression in mice does not enhance macrophage RCT in vivo, and conversely, LCAT-deficient mice display a preserved macrophage RCT despite the severe plasma HDL reduction. In agreement with this observation, defective LCAT activity does not result in enhanced atherosclerosis, despite the reduced HDL cholesterol levels. These findings challenge the notion that LCAT is required for effective atheroprotection and suggest that elevating LCAT expression and/or activity is not a promising therapeutic strategy to reduce cardiovascular risk.
Authors:
Laura Calabresi; Guido Franceschini
Related Documents :
2719765 - Lecithin: cholesterol acyltransferase activity in children and young adults.
15538545 - Acyl coenzyme a:cholesterol acyltransferase inhibitors as hypolipidemic and antiatheros...
9191485 - Reverse cholesterol transport: its contribution to cholesterol catabolism in normal and...
19682715 - Lecithin cholesterol acyltransferase (lcat) activity as a predictor for ketosis and par...
22164765 - Chemical composition and nutrition value of dried cultivated culinary-medicinal mushroo...
22405695 - Comparison of high-protein diets and leucine supplementation in the prevention of metab...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Trends in cardiovascular medicine     Volume:  20     ISSN:  1873-2615     ISO Abbreviation:  Trends Cardiovasc. Med.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-07-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9108337     Medline TA:  Trends Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  50-3     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Affiliation:
Center E. Grossi Paoletti, Department of Pharmacological Sciences, Università degli Studi di Milano, 20133 Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adenosine-triphosphate-binding cassette transporter-1 trafficking and function.
Next Document:  Heat shock protein 27: clue to understanding estrogen-mediated atheroprotection?